• Home
  • Search Results

Search Results

374 studies match your search
Open

NRG-GY026: Testing the addition of HERCEPTIN HYLECTA or PHESGO to the usual chemotherapy for HER2 positive endometrial serous carcinoma or carcinosarcoma

Have you been diagnosed with uterine cancer called endometrial serous carcinoma or carcinosarcoma? If so, you may be able to take part in a research study to test if adding a drug or drugs that target HER2 proteins in addition to the usual combination of chemotherapy drugs could prevent your cancer from returning or shrink your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Open

Blood Test to Predict Recurrence Across Early-Stage Cancers

Are you receiving initial treatment for non-small cell lung cancer or invasive squamous cell carcinoma of the head and neck and want to participate in research that aims to improve treatment and care of future patients with the same diagnosis? If so, you may be able to participate in a study for an investigational blood test to predict whether your cancer will come back.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Open

Lung and Head/Neck Cancer Registry

Do you have known or suspected lung and/or head and neck cancer? Are you scheduled for a tumor biopsy? If so, you may be able to participate in a research registry aimed at learning more about lung and head/neck cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Open

Phase II Study of Trilaciclib and Lurbinectidin

Have you been diagnosed with small cell lung cancer? Is your current treatment no longer working in controlling your cancer? If so, you may be able to take part in a research study looking at giving trilaciclib to help minimize the side effects of lurbinectedin.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
  • Lungs and Breathing
Open

Chronic Myelogenous Leukemia Study

Have you been diagnosed with Leukemia and looking for another option? Do you have Chronic Myelogenous Leukemia? In this study, we want to learn more about how effective the study drug (asciminib) works for patients with CML-CP who have had one prior therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

A randomized open label trial examining the effectiveness of Ofatumumab versus current therapy on relapsing multiple sclerosis.

Are you between 18 and 45 years of age and diagnosed with multiple sclerosis, without MS relapses within the past year? Are you currently prescribed with MS medication? If so, you may be able to participate in a research study examining whether a switch to a high-efficacy medication- Ofatumumab, would work better for you than your current treatment.

Age & Gender
  • 18 years ~ 45 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Immune System/Infections
Open

EAGLE: Efficacy Assessment in recurrent wheezing children

Does your child have recurrent wheezing? They may be able to take part in the EAGLE study to help us learn if a new medication may help.

Age & Gender
  • 6 months ~ 5 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Immune System/Infections
  • Parents of Children
  • and 2 more
Open

TEMPO

Does your memory cause you daily problems? Interested in improving your metabolic health? If you are 65 or older and overweight, you may qualify for a research study examining whether changing the timing of your eating habits can improve your metabolic and brain health.

Age & Gender
  • 65 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Diabetes
  • Obesity
  • and 2 more
Open

Walking Training for Parkinson disease

People with Parkinson disease often develop difficulty walking. Metronomes are thought to help improve walking. We believe that setting metronomes slower while walking on a treadmill and faster when walking over the ground may target certain portions of gait. Our goal is to create beneficial changes in the way that people walk that persist and can be seen in the long-term.

Age & Gender
  • 50 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Physical Disability
  • Movement
Open

This study tests whether RL-007 improves cognitive impairment associated with schizophrenia

Do you have a diagnosis of Schizophrenia? Are you interested in improving your cognitive functioning? If so, you may be eligible to participate in a research study to find out if a new medication "RL-007" improves mental functioning.

Age & Gender
  • 18 years ~ 55 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Mental and Emotional Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research